Peer-reviewedCC BYInternational journal of molecular sciences
Closing the Gap: Advances and Barriers on Candida Vaccines Development in the Last Decade
- 1Department of Pharmaceutical Sciences, University Institute of Health Sciences (IUCS-CESPU), 4585-116 Gandra, Portugal;
- 2Open Innovation Hub for Antimicrobial Surfaces, Surface Science Research Centre, School of Physical Sciences, University of Liverpool, Liverpool L69 3BX, UK;
- 3Associate Laboratory i4HB—Institute for Health and Bioeconomy, University Institute of Health Sciences—CESPU, 4585-116 Gandra, Portugal;
Related
- Recent Advances in Lipid Nanoparticles for Cancer Vaccines: From Antigen Delivery to Personalized Immunotherapy
- Self-Amplifying RNA Vaccines After the First Approvals: Technology, Development Landscape, and Regulatory Science Considerations
- Recent advances in the development of tag-targeted protein degradation systems.
- Report from the 2026 Barth Syndrome Foundation International Scientific, Medical & Family Conference: Advances in Barth Syndrome Research, Therapy Development, and Clinical Care.
- Closing the Translational Gap in Tuberculosis Lipidomics for Resource-Constrained Settings
BibTeX
@article{krier2026closing,
title = {{Closing the Gap: Advances and Barriers on Candida Vaccines Development in the Last Decade}},
author = {Julie Krier and Jontana Allkja and Alexandra Mónica Bastos Viana da Costa and Francisco A. M. Silva and Célia Fortuna Rodrigues},
journal = {International journal of molecular sciences},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13665181},
note = {CC BY},
}
RIS
TY - JOUR
TI - Closing the Gap: Advances and Barriers on Candida Vaccines Development in the Last Decade
AU - Julie Krier
AU - Jontana Allkja
AU - Alexandra Mónica Bastos Viana da Costa
AU - Francisco A. M. Silva
AU - Célia Fortuna Rodrigues
PY - 2026
DA - 2026/09/23
JO - International journal of molecular sciences
UR - https://europepmc.org/article/PMC/PMC13665181
SN - 1422-0067
ER -